Lexaria’s after-hours surge came after the company filed with the Securities and Exchange Commission on Thursday, revealing that it had ended its “Capital on Demand” Sales Agreement with JonesTrading ...

Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal second quarter 2025 results through the filing of its Form 10-Q. Since our previous update, the company has made progress with its multiple ...

As we step into fall, Lexaria Bioscience Corporation (NASDAQ:LEXX) continues to work on multiple GLP-1 trials. Most notably, it reported the last patient-last visit for the Phase Ib study designated ...

(RTTNews) - Several small-cap names posted sharp gains in Thursday's after-hours session, driven by fresh corporate updates, clinical developments, and strategic pivots. Below are five stocks that ...

Fintel reports that on July 21, 2023, Maxim Group initiated coverage of Lexaria Bioscience (NASDAQ:LEXX) with a Buy recommendation. As of July 6, 2023, the average one-year price target for Lexaria ...

A band of misfits aboard a stolen planet-killing starship, the wild, weird Lexx is the best 90s sci-fi show you've never seen. What would Star Wars be like if Darth Vader was possessed by an insect, ...

If you set out to make a movie ripe for ridicule on a show like the canceled Mystery Science Theater 3000, the Sci-Fi Channel’s new series Lexx would provide the perfect formula. This is one of those ...